Page last updated: 2024-09-04

rhodioloside and Cancer of Skin

rhodioloside has been researched along with Cancer of Skin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kong, YH; Xu, SP1
Furmanowa, M; Malinowski, M; Mazurkiewicz, M; Siwicki, AK; Skopińska-Rózewska, E; Sommer, E; Wasiutyński, A1

Other Studies

2 other study(ies) available for rhodioloside and Cancer of Skin

ArticleYear
Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
    Oncology reports, 2018, Volume: 39, Issue:6

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Cytokines; Drug Administration Schedule; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Phenols; Random Allocation; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018
The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice.
    Polish journal of veterinary sciences, 2008, Volume: 11, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Female; Glucosides; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenols; Phytotherapy; Plant Extracts; Random Allocation; Rhodiola; Skin Neoplasms

2008